162 related articles for article (PubMed ID: 1705510)
1. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.
Yamada A; Nojima Y; Sugita K; Dang NH; Schlossman SF; Morimoto C
Eur J Immunol; 1991 Feb; 21(2):319-25. PubMed ID: 1705510
[TBL] [Abstract][Full Text] [Related]
2. Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor.
Yamada A; Nikaido T; Nojima Y; Schlossman SF; Morimoto C
J Immunol; 1991 Jan; 146(1):53-6. PubMed ID: 1670606
[TBL] [Abstract][Full Text] [Related]
3. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
Wasik MA; Morimoto C
J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules.
Davis LS; Oppenheimer-Marks N; Bednarczyk JL; McIntyre BW; Lipsky PE
J Immunol; 1990 Aug; 145(3):785-93. PubMed ID: 1695644
[TBL] [Abstract][Full Text] [Related]
6. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.
Shimizu Y; van Seventer GA; Horgan KJ; Shaw S
J Immunol; 1990 Jul; 145(1):59-67. PubMed ID: 1972721
[TBL] [Abstract][Full Text] [Related]
7. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
8. Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation.
Matsuyama T; Yamada A; Deusch K; Sleasman J; Daley JF; Torimoto Y; Abe T
J Immunol; 1991 Jun; 146(11):3736-41. PubMed ID: 1709660
[TBL] [Abstract][Full Text] [Related]
9. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
[TBL] [Abstract][Full Text] [Related]
10. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
11. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
[TBL] [Abstract][Full Text] [Related]
13. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
14. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
van Noesel CJ; Gruters RA; Terpstra FG; Schellekens PT; van Lier RA; Miedema F
J Clin Invest; 1990 Jul; 86(1):293-9. PubMed ID: 1694865
[TBL] [Abstract][Full Text] [Related]
15. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
[TBL] [Abstract][Full Text] [Related]
16. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
17. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
Koulova L; Yang SY; Dupont B
J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD4 modifies the kinetics but not the magnitude of anti-CD3-induced interleukin 2 production in peripheral T cells.
Jönsson JI; Eichmann K
Eur J Immunol; 1990 Jul; 20(7):1611-4. PubMed ID: 2143730
[TBL] [Abstract][Full Text] [Related]
19. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
[TBL] [Abstract][Full Text] [Related]
20. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
